Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is -41.28% vs -20.04% in Mar 2025
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2026 is 13.91% vs -3.52% in Mar 2025
Investments
YoY Growth in year ended Mar 2026 is 10.00% vs 0.00% in Mar 2025
Current Assets
YoY Growth in year ended Mar 2026 is -24.45% vs -10.67% in Mar 2025
Compare Balance Sheet Results of Beryl Drugs
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
5.09
4.48
0.61
13.62%
Share Warrants & Outstandings
Total Reserve
4.79
-0.64
5.43
848.44%
Shareholder's Funds
9.89
3.84
6.05
157.55%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.00
0.00
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
0.04
-0.00
0.04
0.00%
Other Long Term Liabilities
0.05
0.00
0.05
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.51
0.00
0.51
0.00%
Total Non-Current Liabilities
0.60
-0.00
0.60
0.00%
Current Liabilities
Trade Payables
1.43
1.31
0.12
9.16%
Other Current Liabilities
0.51
0.10
0.41
410.00%
Short Term Borrowings
2.39
0.00
2.39
0.00%
Short Term Provisions
0.15
0.26
-0.11
-42.31%
Total Current Liabilities
4.48
1.67
2.81
168.26%
Total Liabilities
14.96
5.51
9.45
171.51%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
14.94
4.86
10.08
207.41%
Less: Accumulated Depreciation
8.39
3.57
4.82
135.01%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
6.55
1.30
5.25
403.85%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.22
0.00
0.22
0.00%
Long Term Loans & Advances
0.19
0.00
0.19
0.00%
Other Non Current Assets
0.91
0.00
0.91
0.00%
Total Non-Current Assets
8.13
1.30
6.83
525.38%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
3.13
0.63
2.50
396.83%
Sundry Debtors
2.09
1.35
0.74
54.81%
Cash and Bank
0.27
1.64
-1.37
-83.54%
Other Current Assets
1.01
0.38
0.63
165.79%
Short Term Loans and Advances
0.33
0.21
0.12
57.14%
Total Current Assets
6.83
4.21
2.62
62.23%
Net Current Assets (Including Current Investments)
2.35
2.54
-0.19
-7.48%
Total Current Assets Excluding Current Investments
6.83
4.21
2.62
62.23%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
14.96
5.51
9.45
171.51%
Contingent Liabilities
0.30
0.00
0.30
0.00%
Total Debt
2.39
0.00
2.39
0.00%
Book Value per share (adjusted)
19.41
8.58
10.83
126.22%
Annual - Borrowings
Borrowings 2.39 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -41.28% vs -20.04% in Mar 2025
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.05 Cr
in Mar 2026Figures in Cr
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 6.55 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 13.91% vs -3.52% in Mar 2025
Annual - Investments
Investments 0.22 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 10.00% vs 0.00% in Mar 2025
Annual - Current Assets
Current Assets 6.83 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -24.45% vs -10.67% in Mar 2025
